Joint Detection of Serum Vitamin D, Body Mass Index, and Tumor Necrosis Factor Alpha for the Diagnosis of Crohn’s Disease

Abstract

Objective

Vitamin D (VD) deficiency was reported to contribute to the progression of Crohn’s disease (CD) and affect the prognosis of CD patients. This study investigated the role of serum VD, body mass index (BMI), and tumor necrosis factor alpha (TNF-α) in the diagnosis of Crohn’s disease.

Methods

CD patients (n=76) and healthy subjects (n=76) were enrolled between May 2019 and December 2020. The serum 25-hydroxyvitamin D [25(OH)D] levels, BMI, and TNF-α levels, together with other biochemical parameters, were assessed before treatment. The diagnostic efficacy of the single and joint detection of serum 25(OH)D, BMI, and TNF-α was determined using receiver operating characteristic (ROC) curves.

Results

The levels of 25(OH) D, BMI, and nutritional indicators, including hemoglobin, total protein, albumin, and high-density lipoprotein cholesterol, were much lower, and the TNF-α levels were much higher in the CD patients than in the healthy subjects (P<0.05 for all). The areas under the ROC curve for the single detection of 25(OH)D, BMI, and TNF-α were 0.887, 0.896, and 0.838, respectively, with the optimal cutoff values being 20.64 ng/mL, 19.77 kg/m², and 6.85 fmol/mL, respectively. The diagnostic efficacy of the joint detection of 25(OH)D, BMI, and TNF-α was the highest, with an area under the ROC curve of 0.988 (95%CI: 0.968–1.000).

Conclusion

The joint detection of 25(OH)D, TNF-α, and BMI showed high sensitivity, specificity, and accuracy in CD diagnosis; thus, it would be effective for the diagnosis of CD in clinical practice.

Keywords

Crohn’s disease / vitamin D / body mass index / tumor necrosis factor alpha

References

[1] TorresJ, MehandruS, ColombelJF, et al.. Crohn’s disease. Lancet, 2017, 389(10080): 1741-1755

[2] BaumgartDC, SandbornWJ. Crohn’s disease. Lancet, 2012, 80(9853): 1590-1605

[3] NgSC, TangW, ChingJY, et al.. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology, 2013, 145(1): 158-165

[4] MolodeckyNA, SoonIS, RabiDM, et al.. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 2012, 142(1): 46-54

[5] ZhangYZ, LiYY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol, 2014, 20(1): 91-99

[6] LuC, MerrillC, MedellinA, et al.. Bowel Ultrasound State of the Art: Grayscale and Doppler Ultrasound, Contrast Enhancement, and Elastography in Crohn Disease. J Ultrasound Med, 2019, 38(2): 271-288

[7] TaylorSA, MallettS, BhatnagarG, et al.. Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn’s disease patients: the METRIC diagnostic accuracy study. Health Technol Assess, 2019, 23(42): 1-162

[8] RosenCJ. Clinical practice. Vitamin D insufficiency. N Engl J Med, 2011, 364(3): 248-254

[9] ShermanMH, YuRT, EngleDD, et al.. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell, 2014, 159(1): 80-93

[10] JohnsonLA, SauderKL, RodanskyES, et al.. CARD-024, a vitamin D analog, attenuates the pro-fibrotic response to substrate stiffness in colonic myofibroblasts. Exp Mol Pathol, 2012, 93(1): 91-98

[11] AbramovitchS, Dahan-BacharL, SharvitE, et al.. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut, 2011, 60(12): 1728-1737

[12] FrigstadSO, HøivikM, JahnsenJ, et al.. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol, 2017, 52(1): 100-106

[13] KabbaniTA, KoutroubakisIE, SchoenRE, et al.. Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol, 2016, 111(5): 712-719

[14] de BruynJR, van HeeckerenR, PonsioenCY, et al.. Vitamin D deficiency in Crohn’s disease and healthy controls: a prospective case-control study in the Netherlands. J Crohns Colitis, 2014, 8(10): 1267-1273

[15] JørgensenSP, HvasCL, AgnholtJ, et al.. Active Crohn’s disease is associated with low vitamin D levels. J Crohns Colitis, 2013, 7(10): e407-e413

[16] NielsenOH, RejnmarkL, MossAC. Role of Vitamin D in the Natural History of Inflammatory Bowel Disease. J Crohns Colitis, 2018, 12(6): 742-752

[17] ValvanoM, MagistroniM, MancusiA, et al.. The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics. Nutrients, 2021, 13(2): 323

[18] PapadakisKA, TarganSR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med, 2000, 51: 289-298

[19] HeringNA, FrommM, SchulzkeJD. Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol, 2012, 590(5): 1035-1044

[20] JohnLJ, FrommM, SchulzkeJD. Epithelial barriers in intestinal inflammation. Antioxid Redox Signal, 2011, 15(5): 1255-1270

[21] de SouzaHS, FiocchiC. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol, 2016, 13(1): 13-27

[22] SonnenbergA, JacobsenSJ, WassermanIH. Periodicity of hospital admissions for inflammatory bowel disease. Am J Gastroenterol, 1994, 89(6): 847-851

[23] SandallAM, WallCL, LomerMCE. Nutrition Assessment in Crohn’s Disease using Anthropometric, Biochemical, and Dietary Indexes: A Narrative Review. J Acad Nutr Diet, 2020, 120(4): 624-640

[24] DonnellanCF, YannLH, LalS. Nutritional management of Crohn’s disease. Therap Adv Gastroenterol, 2013, 6(3): 231-242

[25] LomerMC, GourgeyR, WhelanK. Current practice in relation to nutritional assessment and dietary management of enteral nutrition in adults with Crohn’s disease. J Hum Nutr Diet, 2014, 27(Suppl 2): 28-35

[26] LiuJB, GaoX, ZhangFB, et al.. The risk factor for low bone mineral density in patients with inflammatory bowel disease. Zhonghua Nei Ke Za Zhi (Chinese), 2009, 48(10): 833-836

[27] TangRH, ChaoK, ZhangSH, et al.. The prevalence and characteristics of anemia in Crohn’s disease in the Chinese. Zhonghua Nei Ke Za Zhi (Chinese), 2013, 52(5): 370-374

[28] YanT, LiL, WuQ, et al.. Analysis of body composition in patients with Crohn’s disease. Zhonghua Wei Chang Wai Ke Za Zhi (Chinese), 2014, 17(10): 981-984

[29] KhanSS, PatilSS. Bone density in pediatric Crohn’s disease: A cross-sectional observation from South India. Indian J Gastroenterol, 2017, 36(3): 184-188

[30] PatsalosO, DaltonB, LeppanenJ, et al.. Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis. Front Pharmacol, 2020, 11: 481

[31] MaaserC, SturmA, VavrickaSR, et al.. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis, 2019, 13(2): 144-164

[32] BestWR, BecktelJM, SingletonJW, et al.. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology, 1976, 70(3): 439-444

[33] World Health Organization. Obesity: Preventing and managing the global epidemic: Report of a WHO consultation. World Health Organ Tech Rep Ser, 2000, 894: 1-253

[34] HolickMF, BinkleyNC, Bischoff-FerrariHA, et al.. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011, 96(7): 1911-1930

[35] AnanthakrishnanAN, KhaliliH, HiguchiLM, et al.. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology, 2012, 142(3): 482-489

[36] BurischJ, PedersenN, Cukovic-CavkaS, et al.. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe—an ECCO-EpiCom study. J Crohns Colitis, 2014, 8(7): 607-616

[37] YangY, CuiX, LiJ, et al.. Clinical evaluation of vitamin D status and its relationship with disease activity and changes of intestinal immune function in patients with Crohn’s disease in the Chinese population. Scand J Gastroenterol, 2021, 56(1): 20-29

[38] LuZL, WangTR, QiaoYQ, et al.. Handgrip Strength Index Predicts Nutritional Status as a Complement to Body Mass Index in Crohn’s Disease. J Crohns Colitis, 2016, 10(12): 1395-1400

[39] CalvertCR, LalS. Approaches to intestinal failure in Crohn’s disease. Proc Nutr Soc, 2011, 70(3): 336-341

[40] GeerlingBJ, Badart-SmookA, StockbrüggerRW, et al.. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr, 2000, 54(6): 514-521

[41] CioffiI, MarraM, ImperatoreN, et al.. Assessment of bioelectrical phase angle as a predictor of nutritional status in patients with Crohn’s disease: A cross sectional study. Clin Nutr, 2020, 39(5): 1564-1571

[42] de CastroMM, CoronaLP, PascoalLB, et al.. Impaired nutritional status in outpatients in remission or with active Crohn’s disease—classified by objective endoscopic and imaging assessments. Clin Nutr ESPEN, 2019, 33: 60-65

[43] PallavK, RicheD, MayWL, et al.. Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective. World J Gastroenterol, 2017, 23(4): 638-645

[44] PrietoJMI, AndradeAR, MagroDO, et al.. Nutritional Global Status and Its Impact in Crohn’s Disease. J Can Assoc Gastroenterol, 2021, 4(6): 290-29

[45] Bendix-StruveM, BartelsLE, AgnholtJ, et al.. Vitamin D3 treatment of Crohn’s disease patients increases stimulated T cell IL-6 production and proliferation. Aliment Pharmacol Ther, 2010, 32(11–12): 1364-1372

[46] LiuN, NguyenL, ChunRF, et al.. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology, 2008, 149(10): 4799-4808

[47] CanaffL, HendyGN. Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1beta. Role of the NF-kappaB pathway and kappaB elements. J Biol Chem, 2005, 280(14): 14177-14188

[48] CanaffL, ZhouX, HendyGN. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. J Biol Chem, 2008, 283(20): 13586-13600

[49] JosephAJ, GeorgeB, PulimoodAB, et al.. 25 (OH) vitamin D level in Crohn’s disease: association with sun exposure & disease activity. Indian J Med Res, 2009, 130(2): 133-137

[50] UlitskyA, AnanthakrishnanAN, NaikA, et al.. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr, 2011, 35(3): 308-316

[51] RafteryT, MerrickM, HealyM, et al.. Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn’s Disease in Clinical Remission. Dig Dis Sci, 2015, 60(8): 2427-2435

[52] JørgensenSP, AgnholtJ, GlerupH, et al.. Clinical trial: vitamin D3 treatment in Crohn’s disease — a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther, 2010, 32(3): 377-383

[53] MechieNC, MavropoulouE, EllenriederV, et al.. Distinct Association of Serum Vitamin D Concentration with Disease Activity and Trough Levels of Infliximab and Adalimumab during Inflammatory Bowel Disease Treatment. Digestion, 2020, 101(6): 761-770

[54] HausmannJ, KubeschA, AmiriM, et al.. Vitamin D Deficiency is Associated with Increased Disease Activity in Patients with Inflammatory Bowel Disease. J Clin Med, 2019, 8(9): 1319

[55] WahlDA, CooperC, EbelingPR, et al.. A global representation of vitamin D status in healthy populations. Arch Osteoporos, 2012, 7: 155-172

[56] HilgerJ, FriedelA, HerrR, et al.. A systematic review of vitamin D status in populations worldwide. Br J Nutr, 2014, 111(1): 23-45

[57] StenczelND, PurcareaMR, TribusLC, et al.. The role of the intestinal ultrasound in Crohn’s disease diagnosis and monitoring. J Med Life, 2021, 14(3): 310-315

[58] LinS, WangY, LiL, et al.. A New Model Based on 25-Hydroxyvitamin D3 for Predicting Active Crohn’s Disease in Chinese Patients. Mediators Inflamm, 2018, 2018: 3275025

[59] NgWL, CollinsPF, HicklingDF, et al.. Evaluating the concurrent validity of body mass index (BMI) in the identification of malnutrition in older hospital inpatients. Clin Nutr, 2019, 38(5): 2417-2422

[60] SnijderMB, van DamRM, VisserM, et al.. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab, 2005, 90(7): 4119-4123

[61] WortsmanJ, MatsuokaLY, ChenTC, et al.. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr, 2000, 72(3): 690-693

[62] LagunovaZ, PorojnicuAC, LindbergF, et al.. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res, 2009, 29(9): 3713-3720

[63] RafteryT, O’SullivanM. Optimal vitamin D levels in Crohn’s disease: a review. Proc Nutr Soc, 2015, 74(1): 56-66

[64] Elizondo-MontemayorL, CastilloEC, Rodríguez-LópezC, et al.. Seasonal Variation in Vitamin D in Association with Age, Inflammatory Cytokines, Anthropometric Parameters, and Lifestyle Factors in Older Adults. Mediators Inflamm, 2017, 2017: 5719461